Direct Versus Indirect Revascularization for Moyamoya: a Large Multicenter Study

Background Moyamoya is a chronic occlusive cerebrovascular disease of unknown etiology causing neovascularization of the lenticulostriate collaterals at the base of the brain. Although revascularization surgery is the most effective treatment for moyamoya, there is still no consensus on the best surgical treatment modality as different studies provide different outcomes. Objective In this large case series, we compare the outcomes of direct (DR) and indirect revascularisation (IR) and compare our results to the literature in order to reflect on the best revascularization modality for moyamoya. Methods We conducted a multicenter retrospective study in accordance with the Strengthening the Reporting of Observational studies in Epidemiology guidelines of moyamoya affected hemispheres treated with DR and IR surgeries across 13 academic institutions predominantly in North America. All patients who underwent surgical revascularization of their moyamoya-affected hemispheres were included in the study. The primary outcome of the study was the rate of symptomatic strokes. Results The rates of symptomatic strokes across 515 disease-affected hemispheres were comparable between the two cohorts (11.6% in the DR cohort vs 9.6% in the IR cohort, OR 1.238 (95% CI 0.651 to 2.354), p=0.514). The rate of total perioperative strokes was slightly higher in the DR cohort (6.1% for DR vs 2.0% for IR, OR 3.129 (95% CI 0.991 to 9.875), p=0.052). The rate of total follow-up strokes was slightly higher in the IR cohort (8.1% vs 6.6%, OR 0.799 (95% CI 0.374 to 1.709) p=0.563). Conclusion Since both modalities showed comparable rates of overall total strokes, both modalities of revascularization can be performed depending on the patient’s risk assessment.

[1]  C. Ogilvy,et al.  Value of Burr‐Hole Surgery as an Adjunct to Encephaloduroarteriosynangiosis in Treatment of Adult Moyamoya Disease: A Case Series , 2022, Stroke: Vascular and Interventional Neurology.

[2]  Aman B Patel,et al.  Direct vs Indirect Revascularization in a North American Cohort of Moyamoya Disease , 2021, Neurosurgery.

[3]  R. Tamargo,et al.  Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres. , 2020, Journal of neurosurgery.

[4]  Summer S. Han,et al.  Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy. , 2020, Journal of neurosurgery.

[5]  V. Biousse,et al.  Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban , 2020, Journal of Stroke and Cerebrovascular Diseases.

[6]  S. Cuschieri The STROBE guidelines , 2019, Saudi journal of anaesthesia.

[7]  Liangjiang Huang,et al.  A Comprehensive Meta-Analysis for Bypass Surgery in Adult Moyamoya. , 2019, World neurosurgery.

[8]  Ji-zong Zhao,et al.  Encephaloduroarteriosynangiosis for Pediatric Moyamoya Disease: A Single-Center Experience With 67 Cases in China , 2018, Journal of child neurology.

[9]  P. Huh,et al.  Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. , 2017, Journal of neurosurgery.

[10]  Qian Zhang,et al.  Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis. , 2017, Journal of neurosurgery.

[11]  G. Steinberg,et al.  Direct Versus Indirect Bypass for Moyamoya Disease. , 2017, Neurosurgery clinics of North America.

[12]  Zarina S Ali,et al.  Direct versus indirect revascularization procedures for moyamoya disease: a comparative effectiveness study. , 2017, Journal of neurosurgery.

[13]  Qian Zhang,et al.  Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease. , 2017, World neurosurgery.

[14]  Xiong-jie Fu,et al.  Indirect Bypass Surgery May Be More Beneficial for Symptomatic Patients with Moyamoya Disease at Early Suzuki Stage. , 2016, World neurosurgery.

[15]  A. Ozpinar,et al.  Perioperative Complications and Long-Term Outcomes After Bypasses in Adults with Moyamoya Disease: A Systematic Review and Meta-Analysis. , 2016, World neurosurgery.

[16]  A. Bailey Acknowledgements , 2016, Biological Psychiatry.

[17]  Jong S. Kim Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis , 2016, Journal of stroke.

[18]  R. Ellenbogen,et al.  Factors associated with the presentation of moyamoya in childhood. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[19]  S. Kuroda,et al.  Effects of Extracranial–Intracranial Bypass for Patients With Hemorrhagic Moyamoya Disease: Results of the Japan Adult Moyamoya Trial , 2014, Stroke.

[20]  J. Diong,et al.  National Institutes of Health Stroke Scale (NIHSS). , 2014, Journal of physiotherapy.

[21]  P. Huh,et al.  Thirteen-year Experience of 44 Patients with Adult Hemorrhagic Moyamoya Disease from a Single Institution: Clinical Analysis by Management Modality , 2013, Journal of cerebrovascular and endovascular neurosurgery.

[22]  R. Du,et al.  Adult moyamoya after revascularization , 2013, Acta Neurochirurgica.

[23]  Rong Wang,et al.  Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  P. Huh,et al.  Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality , 2012, Acta Neurochirurgica.

[25]  R. Scott,et al.  Moyamoya disease and moyamoya syndrome. , 2009, The New England journal of medicine.

[26]  H. van Loveren,et al.  Surgical management of moyamoya disease: a review. , 2009, Neurosurgical focus.

[27]  Jodi L. Smith Understanding and treating moyamoya disease in children. , 2009, Neurosurgical focus.

[28]  D. Newell,et al.  Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. , 2008, Neurosurgical focus.

[29]  Jamie L Banks,et al.  Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis , 2007, Stroke.

[30]  P. Huh,et al.  Surgical results in pediatric moyamoya disease: Angiographic revascularization and the clinical results , 2007, Clinical Neurology and Neurosurgery.

[31]  R. Grubb,et al.  Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon , 2006, Stroke.

[32]  Edward R. Smith,et al.  Surgical Management of Moyamoya Syndrome , 2005, Skull base : official journal of North American Skull Base Society ... [et al.].

[33]  Jodi,et al.  Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. , 2004, Journal of neurosurgery.

[34]  J. Grotta,et al.  Clinical features of moyamoya disease in the United States. , 1998, Stroke.

[35]  S. Mandai,et al.  Surgical treatment of moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms. , 1993, Neurosurgery.

[36]  A Takaku,et al.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.

[37]  S. Shamim,et al.  Neurosurgery , 1985, Springer International Publishing.

[38]  University of Buffalo , 1855, The Buffalo medical journal and monthly review of medical and surgical science.

[39]  C. Cordonnier,et al.  Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience. , 2015, Revue neurologique.

[40]  M. Kawashima,et al.  History of the development of surgical treatments for moyamoya disease. , 2012, Neurologia medico-chirurgica.

[41]  B. Sianesi,et al.  PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing , 2003 .

[42]  S. Miyamoto,et al.  [Moyamoya disease]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.